Ticker LaunchIPO · ABCM
Abcam plc
Abcam plc (ABCM) priced its initial public offering on Oct 22, 2020 at $17.50 per ADS, raising $156.5M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $3.94B. Latham & Watkins advised the company and Davis Polk advised the underwriters.
Abcam plc is a global life science company that identifies, develops and distributes reagents and research tools, including an extensive portfolio of antibodies and related protein research tools. Its customers are mainly scientists in academic institutions, research institutes, and pharmaceutical, biotechnology and diagnostics companies.
- Status
- IPO
- Ticker
- ABCM
- Exchange
- Nasdaq Global Select
- Priced
- Oct 22, 2020
- IPO price
- $17.50 per ADS
- Raised
- $156.5M
- Market cap at IPO price
- $3.94B
- First filed
- Oct 2, 2020
- Company counsel
- Latham & Watkins
- Underwriters' counsel
- Davis Polk
- Sector
- Biotech & pharma
- Country / state
- United Kingdom
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (F-1) first filed Oct 2, 2020
- Latest amendment Oct 21, 2020
- Final prospectus (424B4) Oct 22, 2020
- All filings on EDGAR CIK 1492074
Other Biotech & pharma IPOs in 2020
- Foghorn Therapeutics Inc.FHTX · Oct 23, 2020 · $120M
- Opthea LtdOPT · Oct 19, 2020
- Aligos Therapeutics, Inc.ALGS · Oct 19, 2020 · $150M
- Kiromic Biopharma, Inc.KRBP · Oct 16, 2020 · $15M
- Praxis Precision Medicines, Inc.PRAX · Oct 16, 2020 · $190M
- Tarsus Pharmaceuticals, Inc.TARS · Oct 16, 2020 · $88M